NextCure Inc expected to post a loss of $4.61 a share - Earnings Preview

NextCure

28/07/2025 12:02

NextCure Inc NXTC.OQ NXTC.O is expected to  show no change in quarterly revenue when it reports  results on July 30 (estimated) for the period ending June 30 2025

​LSEG's mean analyst estimate for NextCure Inc is for a loss of $4.61 per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for NextCure Inc is $25.50, about 75.8% above its last closing price of $6.17

This summary was machine generated July 28 at 11:02 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)